Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|September 1, 1996
A prothrombinase-based assay for detection of resistance to activated protein CG A Nicolaes, M C Thomassen, R van Oerle, et al.
European Journal of Biochemistry|August 15, 1992
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein CH M Bakker, G Tans, T Janssen-Claessen, et al.
The Journal of Biological Chemistry|June 10, 1994
Activation of human factor V by meizothrombinG Tans, G A Nicolaes, M C Thomassen, et al.
The Journal of Biological Chemistry|September 8, 1995
Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein CG A Nicolaes, G Tans, M C Thomassen, et al.
The Journal of Biological Chemistry|November 17, 1995
Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein CJ Rosing, L Hoekema, G A Nicolaes, et al.
British Journal of Haematology|May 8, 1999
Acquired APC resistance and oral contraceptives: differences between two functional testsJ Curvers, M C Thomassen, G A Nicolaes, et al.
British Journal of Haematology|November 13, 2001
Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathwayJ Curvers, A W Nap, M C Thomassen, et al.
ERJ Open Research|July 22, 2021
Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β<sub>1</sub> are linked to inflammatory response in sputum of cystic fibrosis patients with <i>Pseudomonas aeruginosa</i>Jan C Thomassen, Tobias Trojan, Maxine Walz, et al.
BMC Pulmonary Medicine|May 7, 2022
The effect of TGF-β<sub>1</sub> polymorphisms on pulmonary disease progression in patients with cystic fibrosisT Trojan, Miguel A Alejandre Alcazar, G Fink, et al.
Thrombosis and Haemostasis|August 6, 2000
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathwaysG Tans, J Curvers, S Middeldorp, et al.
Pageof 3